BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 19342846)

  • 21. Blood pressure management in acute stroke.
    Appleton JP; Sprigg N; Bath PM
    Stroke Vasc Neurol; 2016 Jun; 1(2):72-82. PubMed ID: 28959467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
    Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
    Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal blood pressure circadian rhythm in acute ischaemic stroke: are lacunar strokes really different?
    Castilla-Guerra L; Espino-Montoro A; Fernández-Moreno MC; López-Chozas JM
    Int J Stroke; 2009 Aug; 4(4):257-61. PubMed ID: 19689751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hypertension in the acute phase and in the secondary prevention of stroke].
    Arquizan C
    Rev Prat; 2004 Mar; 54(6):637-40. PubMed ID: 15222615
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive treatment and stroke prevention in patients with and without chronic kidney disease: a review of controlled trials.
    Segall L; Oprisiu R; Fournier A; Covic A
    J Nephrol; 2008; 21(3):374-83. PubMed ID: 18587726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?
    Oprisiu-Fournier R; Faure S; Mazouz H; Boutitie F; Serot JM; Achard JM; Godefroy O; Hanon O; Temmar M; Albu A; Strandgaard S; Wang J; Black SE; Fournier A
    Expert Rev Neurother; 2009 Sep; 9(9):1289-305. PubMed ID: 19769445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of antihypertensive treatment after acute stroke in the Continue or Stop Post-Stroke Antihypertensives Collaborative Study (COSSACS): a prospective, randomised, open, blinded-endpoint trial.
    Robinson TG; Potter JF; Ford GA; Bulpitt CJ; Chernova J; Jagger C; James MA; Knight J; Markus HS; Mistri AK; Poulter NR;
    Lancet Neurol; 2010 Aug; 9(8):767-75. PubMed ID: 20621562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive drugs for acute stroke.
    Blood pressure in Acute Stroke Collaboration (BASC)
    Cochrane Database Syst Rev; 2000; (4):CD002839. PubMed ID: 11034772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of antihypertensive agents on cerebral blood flow and flow velocity in acute ischaemic stroke: systematic review of controlled studies.
    Sare GM; Gray LJ; Bath PM
    J Hypertens; 2008 Jun; 26(6):1058-64. PubMed ID: 18475140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stroke and hypertension. Antihypertensive therapy withdrawal.
    Popa G; Voiculescu V; Popa C; Stănescu A; Nistorescu A; Jipescu I
    Rom J Neurol Psychiatry; 1995; 33(1):29-35. PubMed ID: 7547368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2).
    Delcourt C; Huang Y; Wang J; Heeley E; Lindley R; Stapf C; Tzourio C; Arima H; Parsons M; Sun J; Neal B; Chalmers J; Anderson C;
    Int J Stroke; 2010 Apr; 5(2):110-6. PubMed ID: 20446945
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induced hypertension improves cerebral blood flow in acute ischemic stroke.
    Chalela JA; Dunn B; Todd JW; Warach S
    Neurology; 2005 Jun; 64(11):1979. PubMed ID: 15955961
    [No Abstract]   [Full Text] [Related]  

  • 34. A review of stroke in patients with hypertension and coronary artery disease: Focus on calcium channel blockers.
    Bangalore S; Messerli FH
    Int J Clin Pract; 2006 Oct; 60(10):1281-6. PubMed ID: 16942591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antihypertensive treatment and stroke prevention: are angiotensin receptor blockers superior to other antihypertensive agents?
    Armario P; de la Sierra A
    Ther Adv Cardiovasc Dis; 2009 Jun; 3(3):197-204. PubMed ID: 19443514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of injectable nicardipine for neurovascular indications.
    Reddy P; Yeh YC
    Pharmacotherapy; 2009 Apr; 29(4):398-409. PubMed ID: 19323619
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New Insights into Blood Pressure Control for Intracerebral Haemorrhage.
    Manning LS; Robinson TG
    Front Neurol Neurosci; 2015; 37():35-50. PubMed ID: 26588787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antihypertensive therapy in patients with stroke].
    Kanemaru K; Kanemaru A; Kuwajima I
    Nihon Rinsho; 2001 May; 59(5):945-8. PubMed ID: 11391996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network.
    Dowlatshahi D; Hakim A; Fang J; Sharma M;
    Int J Stroke; 2009 Oct; 4(5):328-34. PubMed ID: 19765119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of candesartan in acute stroke on vascular events during long-term follow-up: results from the Scandinavian Candesartan Acute Stroke Trial (SCAST).
    Hornslien AG; Sandset EC; Igland J; Terént A; Boysen G; Bath PM; Murray GD; Berge E
    Int J Stroke; 2015 Aug; 10(6):830-5. PubMed ID: 25808741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.